Pattern of executive impairment in mild to moderate Parkinson's disease

Dementia and Geriatric Cognitive Disorders

Volumn 36, Issue 1-2, 2013, Pages 50-66

  Kudlicka, Aleksandra ^a   Clare, Linda ^a   Hindle, John V ^b,c  

^a BANGOR UNIVERSITY   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

^c Llandudno LL30 1LB   (United Kingdom)

Author keywords

Abstract reasoning; Attentional control; Cluster analysis; Cognitive impairment; Data driven approach; Delis Kaplan Executive Function System; Frontal type deficits; Neurodegenerative movement disorder

Indexed keywords

AMANTADINE; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; RASAGILINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONCEPT FORMATION; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCREENING TEST; 20 QUESTIONS TEST; ATTENTION; ATTENTION DISTURBANCE; COGNITION ASSESSMENT; DELIS KAPLAN EXECUTIVE FUNCTION SYSTEM; DEPTH PERCEPTION; FRONTAL ASSESSMENT BATTERY; LANGUAGE; MEMORY; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; ORIENTATION; VERBAL FLUENCY;

ADULT; AGED; AGED, 80 AND OVER; ATTENTION; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; STROOP TEST; TRAIL MAKING TEST; VERBAL BEHAVIOR;

EID: 84878953983     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000348355     Document Type: Article

References (79)

1. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I: Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990; 40: 1529-1534
2. Marras C, Lang A: Parkinson's disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry 2013; 84: 409-415
3. Hely MA, Morris JGL, Reid WGJ, Trafficante R: Sydney Multicenter Study of Parkinson's disease: non- L -doparesponsive problems dominate at 15 years. Mov Disord 2005; 20: 190-199
4. Owen AM: Cognitive dysfunction in Parkinson disease: the role of frontostriatal circuitry. Neuroscientist 2004; 10: 525-537
5. Zgaljardic DJ, Borod JC, Foldi NS, Mattis P: A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 2003; 16: 193-210
6. Mindham RHS, Hughes TA: Cognitive impairment in Parkinson's disease. Int Rev Psychiatry 2000; 12: 281- 289
7. Janvin C, Aarsland D, Larsen JP, Hugdahl K: Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003; 15: 126-131
8. Muslimovic D, Post B, Speelman JD, Schmand B: Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-1245
9. McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D: Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease. Dement Geriatr Cogn Disord 2009; 28: 121-129
10. Burgess PW, Alderman N: Executive dysfunction; in Goldstein LH, McNeil JE (eds): Clinical Neuropsychology: A Practical Guide to Assessment and Management for Clinicians. Chichester, Wiley, 2004, pp 209-238
11. Lezak MD: Neuropsychological Assessment, ed 4. New York, Oxford University Press, 2004.
12. Strauss E, Sherman EM, Spreen O: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, Oxford University Press, 2006.
13. Altgassen M, Phillips L, Kopp U, Kliegel M: Role of working memory components in planning performance of individuals with Parkinson's disease. Neuropsychologia 2007; 45: 2393-2397
14. Cools R, Barker RA, Sahakian BJ, Robbins TW: Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 2001; 124: 2503-2512
15. Kobayakawa M, Koyama S, Mimura M, Kawamura M: Decision making in Parkinson's disease: analysis of behavioral and physiological patterns in the Iowa Gambling Task. Mov Disord 2008; 23: 547-552
16. Zgaljardic DJ, Borod JC, Foldi NS, Mattis PJ, Gordon MF, Feigin A, Eidelberg D: An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol 2006; 28: 1127-1144
17. Dujardin K, Defebvre L, Grunberg C, Becquet E, Destee A: Memory and executive function in sporadic and familial Parkinson's disease. Brain 2001; 124: 389-398
18. Bouquet CA, Bonnaud V, Gil R: Investigation of supervisory attentional system functions in patients with Parkinson's disease using the Hayling task. J Clin Exp Neuropsychol 2003; 25: 751-760
19. Kudlicka A, Clare L, Hindle JV: Executive functions in Parkinson's disease: systematic review and metaanalysis. Mov Disord 2011; 26: 2305-2315
20. Uekermann J, Daum I, Bielawski M, Muhlack S, Peters S, Przuntek H, Mueller T: Differential executive control impairments in early Parkinson's disease. J Neural Transm 2004;V(suppl):39-51
21. Dujardin K, Defebvre L, Grunberg C, Becquet E, Destee A: Memory and executive function in sporadic and familial Parkinson's disease. Brain 2001; 124: 389-398
22. Farina E, Gattellaro G, Pomati S, Magni E, Perretti A, Cannata AP, Nichelli P, Mariani C: Researching a differential impairment of frontal functions and explicit memory in early Parkinson's disease. Eur J Neurol 2000; 7: 259-267
23. Colman KSF, Koerts J, van Beilen M, Leenders KL, Post WJ, Bastiaanse R: The impact of executive functions on verb production in patients with Parkinson's disease. Cortex 2009; 45: 930-942
24. Auriacombe S, Grossman M, Carvell S, Gollomp S, Stern MB, Hurtig HI: Verbal fluency deficits in Parkinson's disease. Neuropsychology 1993; 7: 182-192
25. Downes JJ, Sharp HM, Costall BM, Sagar HJ, Howe J: Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment. Brain 1993; 116: 887-902
26. Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron 2003; 39: 889-909
27. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381
28. Dubois B, Pillon B: Cognitive deficits in Parkinson's disease. J Neurol 1997; 244: 2-8
29. Tekin S, Cummings JL: Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002; 53: 647-654
30. Royall DR, Lauterbach EC, Cummings JL, Reeve A, Rummans TA, Kaufer DI, LaFrance WCJ, Coffey CE: Executive control function: a review of its promise and challenges for clinical research. J Neuropsychiatry Clin Neurosci 2002; 14: 377-405
31. Zgaljardic DJ, Foldi NS, Borod JC: Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions. J Neural Transm 2004; 111: 1287-1301
32. Leh SE, Petrides M, Strafella AP: The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology 2010; 35: 70-85
33. Cools R, Miyakawa A, Sheridan M, D'Esposito M: Enhanced frontal function in Parkinson's disease. Brain 2010; 133: 225-233
34. Williams-Gray Ch Jr, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA: The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain 2009; 132: 2958-2969
35. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD: The unity and diversity of executive functions and their contributions to complex 'frontal lobe' tasks: a latent variable analysis. Cogn Psychol 2000; 41: 49-100
36. Stuss DT, Alexander MP: Executive functions and the frontal lobes: a conceptual view. Psychol Res 2000; 63: 289-298
37. Ardila A: On the evolutionary origins of executive functions. Brain Cogn 2008; 68: 92-99
38. Stuss DT, Alexander MP: Is there a dysexecutive syndrome? Philos Trans R Soc Lond B Biol Sci 2007; 362: 901-915
39. Alvarez JA, Emory E: Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 2006; 16: 17-42
40. Aron AR: Progress in executive-function research: from tasks to functions to regions to networks. Curr Dir Psychol Sci 2008; 17: 124-129
41. Norman DA, Shallice T: Attention to action: willed and automatic control of behaviour; in Davidson RJ, Shwartz GE, Shapiro D (eds): Consciousness and Self-regulation: Advances in Research and Theory. New York, Plenum Press 1986, vol 4, pp 1-18
42. Baddeley AD, Hitch GJ: Working memory; in Bower G (ed): Recent Advances in Learning and Motivation. San Diego, Academic Press 1974, vol 8, pp 47-90
43. Weintraub D, Moberg PJ, Culbertson WC, Duda JE, Katz IR, Stern MB: Dimensions of executive function in Parkinson's disease. Dement Geriatr Cogn Disord 2005; 20: 140-144
44. van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J: The identification of Parkinson's disease subtypes using cluster analysis: a systematic review. Mov Disord 2010; 25: 969-978
45. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA: Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005; 76: 343-348
46. Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626
47. Wurtman RJ: Personalized medicine strategies for managing patients with Parkinsonism and cognitive deficits. Metabolism 2013; 62(Suppl 1):S27-S29
48. Woods SP, Tröster AI: Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J Int Neuropsychol Soc 2003; 9: 17-24
49. Janvin CC, Larsen JP, Aarsland D, Hugdahl K: Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006; 21: 1343-1349
50. Hoehn M, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442
51. Daniel SE, Lees AJ: Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 1993; 39: 165-172
52. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR: The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-1085
53. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
54. Snaith RP, Zigmond AS: HADS: Hospital Anxiety and Depression Scale. Windsor, NFER-Nelson, 1994.
55. Reyes M, Lloret S, Gerscovich E, Martin M, Leiguarda R, Merello M: Addenbrooke's Cognitive Examination validation in Parkinson's disease. Eur J Neurol 2009; 16: 142-147
56. Crawford JR, Henry JD, Crombie C, Taylor EP: Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001; 40: 429-434
57. Nelson HE, Willison J: National Adult Reading Test Manual, ed 2. Windsor, NFER-Nelson, 1991.
58. Delis DC, Kaplan E, Kramer JH: The Delis-Kaplan Executive Function System: Examiner's Manual. San Antonio, The Psychological Corporation, 2001. 59 Homack S, Lee D, Riccio CA: Test review: Delis-Kaplan executive function system. J Clin Exp Neuropsychol 2005; 27: 599-609
59. Morris R, Blashfield R, Satz P: Neuropsychology and cluster analysis: potential and problems. J Clin Neuropsychol 1981; 3: 79-99
60. Ward JH: Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963; 58: 236-244
61. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH: Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007; 22: 1272-1277
62. Foltynie T, Brayne CEG, Robbins TW, Barker RA: The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127: 550-560
63. Costa A, Peppe A, Caltagirone C, Carlesimo GA: Prospective memory impairment in individuals with Parkinson's disease. Neuropsychology 2008; 22: 283-292
64. Binder LM, Iverson GL, Brooks BL: Toerr is human: 'abnormal' neuropsychological scores and variability are common in healthy adults. Arch Clin Neuropsychol 2009; 24: 31-46
65. Ingraham LJ, Aiken CB: An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 1996; 10: 120-124
66. Liepelt-Scarfone I, Graeber S, Feseker A, Baysal G, Godau J, Gaenslen A, Maetzler W, Berg D: Influence of different cut-off values on the diagnosis of mild cognitive impairment in Parkinson's disease. Parkinsons Dis 2011; 2011: 540843.
67. Goldman-Rakic P: Dopamine-mediated mechanisms of the prefrontal cortex. Semin Neurosci 1992; 4: 109- 118
68. Miller EK, Cohen JD: An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001; 24: 167-202
69. Seamans JK, Yang CR: The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004; 74: 1-58
70. Badre D, Kayser AS, D'Esposito M: Frontal cortex and the discovery of abstract action rules. Neuron 2010; 66: 315-326
71. Kopp B: A simple hypothesis of executive function. Front Hum Neurosci 2012; 6: 1-6
72. Krawczyk DC, McClelland MM, Donovan CM: A hierarchy for relational reasoning in the prefrontal cortex. Cortex 2011; 47: 588-597
73. Green AE, Fugelsang JA, Kraemer DJ, Shamosh NA, Dunbar KN: Frontopolar cortex mediates abstract integration in analogy. Brain Res 2006; 1096: 125-137
74. Kish SJ, Shannak K, Hornykiewicz O: Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988; 318: 876-880
75. Sawamoto N, Piccini P, Hotton G, Pavese N, Thielemans K, Brooks DJ: Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 2008; 131: 1294-1302
76. Lima CF, Meireles LP, Fonseca R, Castro SL, Garrett C: The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning. J Neurol 2008; 255: 1756-1761
77. Manchester D, Priestley N, Jackson H: The assessment of executive functions: coming out of the office. Brain Inj 2004; 18: 1067-1081
78. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE: Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653
79. Field AP: Discovering Statistics with SPSS, ed 2. London, Sage, 2005.